|
5 patient data entries collated from reference Amiot et al, 2009. Entry # | | Mutations | | allele 1 | allele 2 |
| Clinical representation | Symptoms | Age group | Patient age | Age of onset | Age of death | | | 418 | R309C3
| R309C3
| Peripheral neuropathy, PEO, ataxia, myopathy, fatty liver, pigmentary neuropathy, strokes, epilepsy, dysarthria-dysphonia | | - | movement disorder (ataxia) | |
| | n/a | 14 | 22 | | 419 | M919T1
| A467T2
| Peripheral neuropathy, PEO, ataxia | | - | movement disorder (ataxia) | |
| | 41 | 23 | n/a | | 420 | W748S5 E1143G
| A143V1
| Peripheral neuropathy, PEO, ataxia, hearing loss, dysarthria-dysphonia, urinary tract involvement | | - | movement disorder (ataxia) | |
| | 49 | 40 | n/a | | 421 | D1184N1
| T251I P587L2
| Peripheral neuropathy, PEO, ataxia, epilepsy, fatty liver | | - | movement disorder (ataxia) | |
| | n/a | 9 | 33 | | 422 | D1184N1
| T251I P587L2
| Peripheral neuropathy, PEO, fatty liver | | | n/a | 9 | 30 |
1-5 pathogenic cluster assignment of mutations. Mutations displayed without a superscript number are outside of the assigned pathogenic clusters. See cluster definitions for details.
|